EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
Rite Aid (NYSE:US90274J5618=UBSS), the struggling U.S. pharmacy chain, has agreed to sell pharmacy assets from over 1,000 store locations as part of its ongoing bankruptcy proceedings. Buyers include major retailers like CVS Pharmacy, Walgreens, Kroger (NYSE:KR), Albertsons (NYSE:ACI), and Giant Eagle.
CVS will acquire and operate many Rite Aid and Bartell Drugs stores across Washington, Oregon, and Idaho, according to a recent filing. Despite the asset sales, Rite Aid emphasized that stores will remain open and customers can continue accessing prescription refills, vaccinations, and other pharmacy services without disruption.
The sale primarily involves prescription files and related assets. While Walgreens declined to comment, the other companies involved have yet to issue statements.
This marks Rite Aid’s second bankruptcy filing in under two years, driven by weak retail performance, mounting debt exceeding $2 billion, and ongoing cash flow issues. The Pennsylvania-based company has already received court approval to fast-track the sale of its pharmacy business, with a final approval hearing scheduled for May 21. All transactions are still subject to regulatory approval.
Rite Aid CEO Matt Schroeder said the company aims to ensure a seamless transition for pharmacy customers while minimizing job losses. “These agreements ensure our pharmacy customers will experience a smooth transition while preserving jobs for some of our valued team members,” Schroeder noted.
The move signals a major shift in the U.S. retail pharmacy landscape, as industry giants like CVS and Kroger strengthen their market positions by absorbing Rite Aid’s assets. This development comes as pharmacy chains across the country navigate rising competition, tighter margins, and shifting consumer behavior.
The outcome of the May 21 court hearing will be critical in shaping the next chapter for Rite Aid and its employees.
